Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,028 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.
Nishiyama Y, Kimura K, Otsuka T, Toyoda K, Uchiyama S, Hoshino H, Sakai N, Okada Y, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Minematsu K, Matsumoto M, Tominaga T, Tomimoto H, Terayama Y, Yasuda S, Yamaguchi T; CSPS.com Trial Investigators. Nishiyama Y, et al. Among authors: tominaga t. Stroke. 2023 Mar;54(3):697-705. doi: 10.1161/STROKEAHA.122.039900. Epub 2023 Feb 3. Stroke. 2023. PMID: 36734235 Clinical Trial.
Cilostazol for the prevention of acute progressing stroke: a multicenter, randomized controlled trial.
Shimizu H, Tominaga T, Ogawa A, Kayama T, Mizoi K, Saito K, Terayama Y, Ogasawara K, Mori E; Tohoku Acute Stroke Progressing Stroke Study Group. Shimizu H, et al. Among authors: tominaga t. J Stroke Cerebrovasc Dis. 2013 May;22(4):449-56. doi: 10.1016/j.jstrokecerebrovasdis.2013.02.009. Epub 2013 Mar 29. J Stroke Cerebrovasc Dis. 2013. PMID: 23541423 Clinical Trial.
Risk of rupture of unruptured cerebral aneurysms in elderly patients.
Hishikawa T, Date I, Tokunaga K, Tominari S, Nozaki K, Shiokawa Y, Houkin K, Murayama Y, Ishibashi T, Takao H, Kimura T, Nakayama T, Morita A; For UCAS Japan and UCAS II Investigators. Hishikawa T, et al. Neurology. 2015 Nov 24;85(21):1879-85. doi: 10.1212/WNL.0000000000002149. Epub 2015 Oct 28. Neurology. 2015. PMID: 26511450 Free PMC article.
Effects of Surgery and Antiplatelet Therapy in Ten-Year Follow-Up from the Registry Study of Research Committee on Moyamoya Disease in Japan.
Yamada S, Oki K, Itoh Y, Kuroda S, Houkin K, Tominaga T, Miyamoto S, Hashimoto N, Suzuki N; Research Committee on Spontaneous Occlusion of Circle of Willis (Moyamoya Disease). Yamada S, et al. Among authors: tominaga t. J Stroke Cerebrovasc Dis. 2016 Feb;25(2):340-9. doi: 10.1016/j.jstrokecerebrovasdis.2015.10.003. Epub 2015 Nov 30. J Stroke Cerebrovasc Dis. 2016. PMID: 26654669
Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products.
Houkin K, Shichinohe H, Abe K, Arato T, Dezawa M, Honmou O, Horie N, Katayama Y, Kudo K, Kuroda S, Matsuyama T, Miyai I, Nagata I, Niizuma K, Sakushima K, Sasaki M, Sato N, Sawanobori K, Suda S, Taguchi A, Tominaga T, Yamamoto H, Yamashita T, Yoshimine T; Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction. Houkin K, et al. Among authors: tominaga t. Stroke. 2018 Apr;49(4):e145-e152. doi: 10.1161/STROKEAHA.117.019216. Epub 2018 Mar 16. Stroke. 2018. PMID: 29581346 Review. No abstract available.
Development of Hemorrhage-prone Anastomoses in Asymptomatic Moyamoya Disease-A Comparative Study with Japan Adult Moyamoya Trial.
Yamamoto S, Funaki T, Fujimura M, Takahashi JC, Uchino H, Houkin K, Tominaga T, Miyamoto S, Kuroda S; Asymptomatic Moyamoya Registry Investigators and the Japan Adult Moyamoya Trial Investigators. Yamamoto S, et al. Among authors: tominaga t. J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104328. doi: 10.1016/j.jstrokecerebrovasdis.2019.104328. Epub 2019 Aug 27. J Stroke Cerebrovasc Dis. 2019. PMID: 31471213
2,028 results